The global jet injector device market size will grow by USD 260.78 million during 2019-2023. This market report provides a detailed analysis of the market by type (powder and liquid and depot) and geography (Asia, Europe, North America, and ROW). Also, the report analyzes the market's competitive landscape and offers information on many market vendors, including Antares Pharma Inc., Beijing Kushur Medical Technology Co. Ltd., Crossject, Endo International Plc, European Pharma Group BV, INJEX Pharma GmbH, Inovio Pharmaceuticals Inc., Medical International Technologies Inc., National Medical Products Inc., and PharmaJet Inc.
Key Insights on Jet Injector Device Market - Global Forecast 2019-2023

Browse TOC and LoE with selected illustrations and example pages of on jet injector device market
Industry Overview
The rising prevalence of conditions such as diabetes, arthritis, and Parkinson's disease has increased the demand for self-injectable drug delivery devices. With advances in treatment techniques, self-administration methods have gained popularity. The geriatric population, who are prone to developing chronic health conditions, exhibit low patient compliance with injectable drug delivery devices. Also, these devices increase the risk of infection, overdose, and injury. Vendors have capitalized on these limitations and have started offering needle-free jet injectors. The increasing rate of self-administration of drugs under homecare settings has increased the demand for less invasive jet injectors. This will lead to the growth of the jet injector device market during 2019-2023.
Most of the pharmaceutical and biopharmaceutical companies have been carrying out extensive R&D on new therapeutics to treat many existing and new diseases. One of the recent developments is biologics. Biologics are available in many forms, including vaccination that requires a delivery system. The needle-free technology used in jet injections is highly effective for DNA vaccinations. Biopharmaceutical companies are also developing biologic vaccinations to treat cancer and certain neurological disorders. In addition to the development of less-invasive drug delivery devices, the rising focus on biologics to treat various prevalent health conditions will also drive market growth over the forecast period. This jet injector device market analysis predicts that as a result of these factors, the market will register a CAGR of almost 8%.
Top Companies in Jet Injector Devices Market
The global market is moderately fragmented. To help clients improve their market positions, this jet injector device market forecast report provides an analysis of the market's competitive landscape and offers information on the products offered by various companies. This report also includes information on the upcoming jet injector device market trends and challenges that will influence market growth. This will help companies in creating strategies to make the most of future growth opportunities.
The report offers a detailed analysis of several leading jet injector device manufacturers, including:
- Antares Pharma, Inc.
- Beijing Kushur Medical Technology Co. Ltd.
- Crossject
- Endo International Plc
- European Pharma Group BV
- INJEX Pharma GmbH
- Inovio Pharmaceuticals Inc.
- Medical International Technologies Inc.
- National Medical Products Inc.
- PharmaJet Inc.
Market Segmentation
Jet Injector Devices Market by Type
- Powder and liquid
- Depot
The powder and liquid injectors segment held the largest market share in 2018 and will account for the highest jet injector device market share over the forecast period as well. Powder- and liquid-based load types are commonly used in jet injections, which can disperse the medication evenly on the area of action.
Moreover, these forms of medication are fast-acting and have delayed-release forms. These factors will boost the growth of the market segment during the forthcoming years. This report provides an accurate prediction of the contribution of all the segments to the growth of the jet injector device market size.
Jet Injector Devices Market by Region
- Asia
- Europe
- North America
- ROW
With a complete study of the growth opportunities for companies, it has been identified that North America will account for the highest share of the jet injector device market throughout the forecast period. Factors such as the rising adoption of advanced technology in the healthcare sector, high awareness of self-administration in patients, and the growing prevalence of chronic and infectious diseases contribute to jet injector device industry growth in the region.
Major Highlights of the Jet Injector Devices Market - Global Forecast 2019-2023
- CAGR of the market during the forecast period 2019-2023
- Detailed information on factors that will accelerate the growth of the jet injector device market size during the next five years
- Precise estimation of the global jet injector device market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the jet injector device industry Asia, Europe, North America, and ROW
- A thorough analysis of the market's competitive landscape and detailed information on several vendors
- Comprehensive details of factors that will challenge the growth of jet injector device companies
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch